𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy

✍ Scribed by Lawrence R. Dick; Paul E. Fleming

Book ID
113569082
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
483 KB
Volume
15
Category
Article
ISSN
1359-6446

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Synergistic anti-proliferative and pro-a
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells
✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 356 KB πŸ‘ 1 views

## Abstract The proteasome plays a pivotal role in the turnover of regulatory transduction proteins induced by activated cell membrane growth factor receptors. The epidermal growth factor receptor (EGFR) pathway is crucial in the development and progression of human epithelial cancers. Proteasome i

Synergistic anti-proliferative and pro-a
Synergistic anti-proliferative and pro-apoptotic activity of combined therapy with bortezomib, a proteasome inhibitor, with anti-epidermal growth factor receptor (EGFR) drugs in human cancer cells
✍ Tina Cascone; Maria Pia Morelli; Floriana Morgillo; Woo-Young Kim; Gabriella Rod πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 29 KB πŸ‘ 1 views

## Abstract The article to which this erratum refers was published in J Cell Physiol (2008) 216: 698–707. Β© 2008 Wiley‐Liss, Inc. DOI: 10.1002/jcp.21444